The North American Association of Central Cancer Registries, Inc. (NAACCR) has received CEO Cancer Gold Standard™ accreditation, recognizing the company’s commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment for their own employees and their covered family members.
Christopher A. Viehbacher, chief executive officer of Sanofi, chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard™, in collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit organizations and professionals. Today, more than two million employees and family members are benefiting from the vision and leadership of employers like NAACCR who have chosen to become Gold Standard accredited.
“This Gold Standard accreditation is an acknowledgement of NAACCR’s leadership by example and the organization’s commitment to health, starting with the health of NAACCR’s employees and family members,” said Christopher A. Viehbacher, CEO of Sanofi.
The CEO Cancer Gold Standard™ calls for companies to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. To earn Gold Standard accreditation, a company must establish programs to reduce cancer risk by discouraging tobacco use; encouraging physical activity; promoting healthy diet and nutrition; detecting cancer at its earliest stages; and providing access to quality care, including participation in clinical trials.
About the North American Association of Central Cancer Registries, Inc. (NAACCR)
Established in 1987, the North American Association of Central Cancer Registries, Inc. (NAACCR), is a collaborative umbrella organization for cancer registries, governmental agencies, professional organizations, and private groups in North America interested in enhancing the quality and use of cancer registry data. Its goal is to set standards and build consensus for the collection of uniform cancer data across the continent. All state and provincial central cancer registries in the United States and Canada are members.